Amyris, a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, sold its Vitamin E royalty agreement to Koninklijke DSM N.V. (Royal DSM). This agreement assigns Amyris’s rights to Vitamin E royalties to DSM in exchange for total consideration of approximately $57 million. In addition, DSM and Amyris have agreed to a further manufacturing cooperation for Amyris products at DSM’s Brotas facility that provides additional capacity and lower cost of goods sold with an expected approximate aggregate benefit of $30–$40 million over the next three years. The expected economic benefit of both agreements to Amyris is approximately $90 million.
Royal DSM, a Dutch global science-based company in Nutrition, Health and Sustainable Living, intends to create a 75/25 joint venture with Nenter & Co., Inc., which will include all Nenter’s production and related assets for Vitamin E.
Royal DSM, the Dutch global science-based company in Nutrition, Health and Sustainable Living, is helping professional cyclists Team Sunweb to recover faster in this year’s Tour de France with its dietary antiplatelet, Fruitflow®. This forms part of the innovation partnership between DSM and Team Sunweb that aims to improve the health, nutrition and cycling materials of the professional athletes.
Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.
A total of eight promising start-ups were invited to pitch at the event “Connecting Bright Innovations 2017” organised by Royal DSM and held this year in Delft (Netherlands), which focused on new and innovative products and biotechnologies for food, health and (bio)tech applications. A panel of expert venturing and innovation specialists is evaluating the pitches with a view to their suitability for further financing and partnering opportunities.
A new deal in the animal feed sector. Royal DSM, the Dutch global science-based company active in health, nutrition and materials, acquired Twilmij B.V., a well-established Dutch nutritional solutions company in the animal feed sector.
Amyris, the U.S. industrial bioscience company led by John Melo, closed the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25 million investment from Koninklijke DSM N.V. (Royal DSM) with the remaining $25 million contributed by Vivo Capital.
Amyris, Inc., the U.S. industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM), the Dutch global science-based company active in health, nutrition and materials, have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health and nutrition markets (including vitamins and other nutritional ingredients).
Royal DSM, the global Life Sciences and Materials Sciences company headquartered in The Netherlands, announced yesterday a “substantial investment” in its Wilmington, Massachusetts (USA) manufacturing facility in order to produce waterborne resins for inks and coatings. Driven by its commitment to grow the sustainable coatings market, DSM will
upgrade its facilities to produce state-of-the-art waterborne resins for inks and coatings.